Get ready for a journey into the depths of biochemistry, measurement and clinical significance of Lipoprotein(a).
In this presentation Ken Sikaris provides the most recent evidence around this not well understood lipid. He explains the random nature and risks associated with elevated Lipoprotein(a) as well as suggesting which populations would benefit from testing.
- The biochemistry of Lp(a)
- How it differs from LDL
- What dietary patterns help reduce it
A/Prof Ken Sikaris BSc(Hons), MBBS, FRCPA, FAACB, FFSc trained as a scientist, then medical practitioner, at Melbourne University before settling as a chemical pathologist who now has three decades of experience in public and private laboratories. Ken has hundreds of publications and holds several international committee roles particularly in the field of interpretation, reference intervals and clinical decision limits.